Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.66 |
| ▸ | KRAS | P01116 | 8/20 | 0.63 |
| ▸ | NT5E | P21589 | 1/20 | 0.61 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.60 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.57 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.57 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.57 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.57 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.55 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.55 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.55 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.54 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.54 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glucuronic Acid SCHEMBL27957333 | 1.00 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| Glucuronic Acid SCHEMBL6046180 | 1.00 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| L-Fucose SCHEMBL20607674 | 0.92 | TGM2 (0.67) | TGM2KRASNT5EFUT5P2RY2 | |
| L-Fucose SCHEMBL18992533 | 0.92 | TGM2 (0.67) | TGM2KRASNT5EFUT5P2RY2 | |
| Demannose SCHEMBL2182862 | 0.92 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| Galactose SCHEMBL6046113 | 0.92 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| Demannose SCHEMBL20746287 | 0.92 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| Demannose SCHEMBL4290630 | 0.92 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| Demannose SCHEMBL5163477 | 0.92 | TGM2 (0.66) | TGM2KRASNT5EFUT5P2RY2 | |
| Xylose SCHEMBL1422097 | 0.91 | TGM2 (0.67) | TGM2KRASNT5EFUT5P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060121019-A1 | Compositions for treating cystic fibrosis | BUDNY JOHN A | 2006-06-08 | — | — | US | disclosed |
| US-20050158253-A1 | Enzyme and an enzyme-anchor complex; degrades biofilm structures; complex acts as a bactericide | PHARMACAL BIOTECHNOLOGIES, LLC. | 2005-07-21 | — | — | US | disclosed |
| US-6830745-B1 | Compositions for treating biofilm | PHARMACAL BIOTECHNOLOGIES, LLC | 2004-12-14 | — | — | US | disclosed |
| US-20030206875-A1 | Compositions for treating biofilm | PHARMACAL BIOTECHNOLOGIES, LLC. | 2003-11-06 | — | — | US | disclosed |
| US-20020037260-A1 | Compositions for treating biofilm | BUDNY JOHN A (US) | 2002-03-28 | — | — | US | disclosed |
| US-20020022005-A1 | Compositions for treating cystic fibrosis | ALLOTROPE PHARMACEUTICALS, INC. | 2002-02-21 | — | — | US | disclosed |